The purpose of this study was to evaluate the shortterm safety and tolerability of a single dose of FCM (15 mg/kg; maximum of 1000 mg) over 15 minutes vs. placebo in a variety of populations with IDA.
Details
- Topic
- Research and reports
- Date published
- 04 Jul 2013
- Size
- 8 pages
- Author
- Department of Health & Human Services
- Update frequency
- Annual
- Available format
Reviewed 05 July 2013